Help
Options
Didn't know it?
click below
click below
Knew it?
click below
click below
Don't Know
Remaining cards (0)
Know
retry
shuffle
restart
0:00
Embed Code - If you would like this activity on your web page, copy the script below and paste it into your web page.
Normal Size Small Size show me how
Normal Size Small Size show me how
PharmTechCh10
chapter 10 multiple choice
| Question | Answer |
|---|---|
| The study of factors associated with drug products and physiological processes and the resulting systemic concentrations of the drugs is: a. bioequivalency b. biopharmaceutics c. active transport | b. biopharmaceutics |
| The location where an administered drug produces an effect is: a. site of action b. selective action c. onset of action | b. site of action |
| The cellular material at the site of action which interacts with the drug is: a. nephron b. metabolite c. receptor | c. receptor |
| The characteristics of a drug that makes its action specific to certain receptors and the tissues they affect is: a. selective action b. first pass metabolism c. gastric emptying time | a. selective action |
| Drugs that activate receptors to accelerate or slow normal cell function is: a. antagonist b. agonist c. receptor | b. agonist |
| Drugs that bind with receptors but do not activate them: a. agonist b. hydrophobic c. antagonist | c. antagonist |
| The blood concentration needed of a drug to produce a response is: a. minimum toxic concentration b. therapeutic window c. minimum effective concentration | c. minimum effective concentration |
| The time MEC is reached and the response occurs is: a. passive diffusion b. onset of action c. selective action | b. onset of action |
| A drug's blood concentration range between its MEC and MTC is: a. therapeutic equivalent b. site of action c. therapeutic window | c. therapeutic window |
| A term sometimes used to refer to all of the ADME processes together: a. metabolism b. excretion c. disposition | c. disposition |
| The movement of drugs from an area of high concentration to lower concentration is: a. passive diffusion b. selective action c. first pass metabolism | a. passive diffusion |
| The movement of drug molecules across membranes by active means, rather than passive diffusion: a. active transport b. selective action c. receptor | a. active transport |
| Term meaning water repellent: a. hydrophilic b. hydrophobic c. lipoidal | b. hydrophobic |
| Capable of associating with or absorbing water is: a. receptor b. nephron c. hydrophylic | c. hydrophylic |
| A fat like substance is: a. lipoidal b. metabolite c. agonist | a. lipoidal |
| The time a drug will stay in the stomach before it is emptied into the small intestine is: a. glomerular filtration b. gastric emptying time c. protein binding | b. gastric emptying time |
| Formed when molecules of different chemicals attach to each other, as in protein binding is: a. disposition b. bioavailability c. complex | c. complex |
| The attachment of a drug molecule to a plasma or tissue protein, effectively making the drug inactive, but keeping it in the body is: a. passive diffusion b. protein binding c. first pass metabolism | b. protein binding |
| The substance resulting from the body's transformation of an administered drug is: a. enzyme induction b. enzyme inhibition c. metabolite | c. metabolite |
| A complex protein that causes chemical reactions in other substances is: a. enzyme b. nephron c. receptro | a. enyzme |
| The increase in enzyme activity that results in greater metabolism of drugs is: a. enzyme induction b. enzyme inhibition c. enzyme | a.enzyme induction |
| The decrease in enzyme activity that results in reduced metabolism of drugs is: a. hydrophobic b. antagonist c. enzyme inhibition c. | c. enzyme inhibition |
| The substantial degradation of a drug caused by enzyme metabolism in the liver before the drug reaches the systemic circulation is: a. selective action b. first pass metabolism c. passive diffusion | b. first pass metabolism |
| The transfer of drugs and their metabolites from the liver to the bile in the gall bladder and then the intestine is: a. enterohepatic cyclying b. glomerular filtration c. therapeutic equivalent | a. enterohepatic cyclying |
| The functional unit of the kidneys is the: a. spleen b. bladder c. nephron | c. nephron |
| The blood filtering process of the kidneys is: a. nephron b. glomerular filtration c. kidney | b. glomerular filtration |
| The relative amount of an administered dose that reaches the general circulation and the rate at which this occurs is: a. bioavailability b. bioequivalency c. biopharmaceutics | a. bioavailability |
| The comparison of bioavailabity between two dosage forms is: a. pharmaceutical equivalent b. therapeutic window c. bioequivalency | c. bioequivalency |
| Drug products that contain identical amounts of the same active ingredients in the same dosage form is an: a. pharmaceutical equivalent b. pharmaceutical alternative c. pharmacology | a. pharmaceutical equivalent |
| Drug products that contain the same active ingredients, but not necessarily in the same amount or dosage form is: a. therapeutic alternative b. pharmaceutical alternative c. pharmacopeia | b. pharmaceutical alternative |
| Pharmaceutical equivalents that produce the same effects in patients is; a. bioequivalency b. therapeutic window c. therapeutic equivalent | c. therapeutic equivalent |
| First pass metabolism occurs at the: a. stomach b. liver c. kidney | b. liver |
| The process of elimination and excretion is: a). absorption b). metabolism c). elimination | c. elimination |
Created by:
kiamia_76
Popular Pharmacology sets